Sažetak
Background: Accurate biochemical monitoring is central to effective diabetes management. This study investigated the effect of the National Standardized Metabolic Management Center (MMC)-assisted glycemic control assistant on laboratory-based glucose metabolism parameters in patients with type 2 diabetes.
Methods: A retrospective study was conducted on 160 patients with type 2 diabetes, including 95 who received MMC-assisted digital management and 65 who received routine care. Key biochemical parameters—fasting plasma glucose (FPG), 2-hour postprandial glucose (2hPG), and glycated hemoglobin (HbA1c)—were measured using standardized enzymatic assays. Dietary behavior and diabetes self-management were also assessed using validated scales.
Results: Baseline biochemical markers and behavioral scores showed no significant differences between groups. After intervention, the MMC-assisted group demonstrated significantly lower levels of FPG (7.42±2.43 vs. 8.30±2.66 mmol/L, P=0.032), 2hPG (10.23±3.21 vs. 12.39±3.50 mmol/L, P<0.001), and HbA1c (7.26±2.05% vs. 7.98±2.34%, P=0.041) compared to controls. Improvements were also observed in dietary behavior and self-management, including better adherence to blood glucose monitoring and medication.
Conclusion: The MMC-assisted glycemic control assistant significantly improves biochemical markers of glucose metabolism in patients with type 2 diabetes. This laboratory-confirmed improvement supports the integration of digital tools into standardized metabolic disease management.
Ključne reči
Array
Array
Array
Array
Array
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.